Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women
Sponsor: Brigham and Women's Hospital
Listed as NCT00000479, this PHASE3 trial focuses on Cardiovascular Diseases and Cerebrovascular Disorders and remains completed. Sponsored by Brigham and Women's Hospital, it has been updated 7 times since 1992, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Sep 1992
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.